23-hydroxy budesonide

ID: ALA3542193

Chembl Id: CHEMBL3542193

PubChem CID: 118753367

Max Phase: Preclinical

Molecular Formula: C25H34O7

Molecular Weight: 446.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(O)C1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1

Standard InChI:  InChI=1S/C25H34O7/c1-4-17(28)22-31-20-10-16-15-6-5-13-9-14(27)7-8-23(13,2)21(15)18(29)11-24(16,3)25(20,32-22)19(30)12-26/h7-9,15-18,20-22,26,28-29H,4-6,10-12H2,1-3H3/t15-,16-,17?,18-,20+,21+,22?,23-,24-,25+/m0/s1

Standard InChI Key:  OBFKEHNWUXWRPI-BZGQYQIDSA-N

Alternative Forms

  1. Parent:

    ALA3542193

    ---

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A5 Tclin Cytochrome P450 3A5 (525 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A7 Tclin Cytochrome P450 3A7 (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.54Molecular Weight (Monoisotopic): 446.2305AlogP: 1.69#Rotatable Bonds: 4
Polar Surface Area: 113.29Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.26CX Basic pKa: CX LogP: 1.89CX LogD: 1.89
Aromatic Rings: Heavy Atoms: 32QED Weighted: 0.60Np Likeness Score: 2.46

References

1. Moore CD, Roberts JK, Orton CR, Murai T, Fidler TP, Reilly CA, Ward RM, Yost GS..  (2013)  Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.,  41  (2): [PMID:23143891] [10.1124/dmd.112.046318]

Source